Friday, July 17, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Allianz Defies Jefferies’ Stubborn €325 Target as Buyback Hits €1.5B and Bullish Calls Multiply

Kennethcix by Kennethcix
July 17, 2026
in Analysis, Banking & Insurance, DAX
0
Allianz Stock
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

For more than six months, Allianz shares have traded well above Jefferies’ price target of €325 — a gap that analyst Philip Kett himself describes as unusually wide. Yet the stock continues to hover near a 52-week high of €425.50, reached on July 10, and closed Friday at €423.00, just 0.59% shy of that mark. The disconnect between market optimism and one of Wall Street’s more conservative voices has only widened as the insurer’s buyback program gains steam and a growing chorus of analysts lifts their sights.

Jefferies has held its “Hold” rating and €325 target since December 2024, even as Allianz surged 21% over the past twelve months. Kett reiterated the stance on July 14, the same day the stock hit its recent peak, citing the need for sustained margin improvement in the property-casualty business before he can turn more constructive. The persistence of that view stands in stark contrast to the bullish momentum building elsewhere.

The buyback program, launched in February with a €2.5 billion authorization, provides a tangible backstop. By early July, Allianz had repurchased roughly 3.95 million shares for about €1.5 billion, including one million shares bought in June alone. Such aggressive repurchases signal management’s confidence in the company’s valuation and typically support share demand. Meanwhile, asset manager Amundi trimmed its stake below the 3% reporting threshold in early June, though the move appears routine for a large fund house and carries no strategic implications.

Analysts at Metzler and Berenberg take a far more upbeat view. On July 17, Metzler raised its price target to €454 from €410, reaffirming a buy recommendation. Berenberg went further on July 16, reiterating a buy with a €684 target — the highest on the Street — and pointing to a potential windfall from Germany’s pension reform, which could boost demand for Allianz’s retirement products. Even the Frankfurter Allgemeine Zeitung joined the bullish camp on July 17, adding the stock to its “Technical Depot” on the strength of a confirmed long-term uptrend and clear outperformance versus the sector index. The shares now trade about 12% above their 200-day moving average, a classic sign of relative strength.

Should investors sell immediately? Or is it worth buying Allianz?

That optimism rests on a solid first-quarter performance. On May 13, Allianz reported operating profit of €4.517 billion, up 6.6% from €4.236 billion a year earlier. Total business volume rose 3.5% to €53.0 billion, while the Solvency II capital ratio stood at a comfortable 221%. Shareholders approved a €17.10 dividend for fiscal 2025 at the annual meeting on May 7 — an 11% increase from the prior year’s €15.40.

Investors now look to August 7, when Allianz releases second-quarter and first-half results. With the stock near its record and 30-day volatility at 10.32%, the market will be watching closely to see whether operating momentum from Q1 persists — and whether the coming data will validate the sceptics at Jefferies or the optimists aiming for €454 and beyond.

On the strategic front, Allianz continues to expand in Asia and embrace technology. In April, it signed a binding agreement with Jio Financial Services to form a 50-50 joint venture covering property and health insurance in India. Japan operations were rebranded in early July under the global “One Brand Strategy,” with Allianz Worldwide Partners Japan becoming Allianz Partners Japan. And at its July 13 “Media Barbecue,” management outlined a broader AI deployment plan under the guiding principle of “Trust,” aiming to improve claims processing and customer service — though no specific cost savings or revenue targets were disclosed.

Ad

Allianz Stock: Buy or Sell?! New Allianz Analysis from July 17 delivers the answer:

The latest Allianz figures speak for themselves: Urgent action needed for Allianz investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 17.

Allianz: Buy or sell? Read more here...

Tags: Allianz
Kennethcix

Kennethcix

Related Posts

Caterpillar Stock
Analysis

Caterpillar’s Two-Speed Engine: Record Backlog Masks Cyclical Headwinds

July 17, 2026
Applovin Stock
Analysis

AppLovin’s Insider Exodus and Pixel Slowdown Raise Questions Ahead of Earnings

July 17, 2026
Pentixapharm Stock
Analysis

Pentixapharm’s Busy Week: FDA Fast-Track, Rights Offering, and a BaFin Review All in Play

July 17, 2026
Next Post
ABB Stock

Record Orders and a Pricy Takeover: ABB Stakes Its Future on Rotork and a Robotics Exit

Recommended

Unitedhealth Stock

Could Warren Buffett’s Investment Signal a Turnaround for UnitedHealth?

11 months ago
Amazon Stock

Amazon’s AI Ambitions Offset by Logistics Headwinds

4 months ago
Commerzbank Stock

Commerzbank’s Standalone Strategy Intensifies as BaFin Clamps Down on UniCredit

3 months ago
TKMS Stock

TKMS: A Naval Giant’s Fate Hinges on Three Critical Weeks

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

AppLovin’s Insider Exodus and Pixel Slowdown Raise Questions Ahead of Earnings

Pentixapharm’s Busy Week: FDA Fast-Track, Rights Offering, and a BaFin Review All in Play

Lang & Schwarz Trades Below Book Value as It Unveils €30m Structured Products Profit and €2 Dividend

Behind Micron’s 25% Rout: A Fully Booked HBM Pipeline and $25 Billion in New Factories

SanDisk’s Plunge Meets a Wall of Institutional Buying as Analysts Split on AI Demand

From Cost Center to Cloud: Meta’s Infrastructure Avalanche Meets a Skeptical Analyst

Trending

ABB Stock
European Markets

Record Orders and a Pricy Takeover: ABB Stakes Its Future on Rotork and a Robotics Exit

by Rodolfo Hanigan
July 17, 2026
0

ABB is in the midst of a sweeping portfolio overhaul that few investors expected to come at...

Allianz Stock

Allianz Defies Jefferies’ Stubborn €325 Target as Buyback Hits €1.5B and Bullish Calls Multiply

July 17, 2026
Caterpillar Stock

Caterpillar’s Two-Speed Engine: Record Backlog Masks Cyclical Headwinds

July 17, 2026
Applovin Stock

AppLovin’s Insider Exodus and Pixel Slowdown Raise Questions Ahead of Earnings

July 17, 2026
Pentixapharm Stock

Pentixapharm’s Busy Week: FDA Fast-Track, Rights Offering, and a BaFin Review All in Play

July 17, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Record Orders and a Pricy Takeover: ABB Stakes Its Future on Rotork and a Robotics Exit
  • Allianz Defies Jefferies’ Stubborn €325 Target as Buyback Hits €1.5B and Bullish Calls Multiply
  • Caterpillar’s Two-Speed Engine: Record Backlog Masks Cyclical Headwinds

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com